|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08225 C HEALTH GP
Nominal 
0.179 0.000 (0.000%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 21,425 | 63.675% | 13,090 | 83,601 | 83,063 | 63,216 |
| Cost of Sales | (13,213) | 79.842% | (7,347) | (19,744) | -- | -- |
| Gross Profit | 8,212 | 42.991% | 5,743 | 63,857 | -- | -- |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | (381) | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | 18 | 15,585 | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (58,211) | 267.819% | (15,826) | 42,521 | 70,796 | 32,454 | |
| Taxation | 0 | -- | 0 | (6,196) | (10,146) | (4,662) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 197 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (58,014) | 266.574% | (15,826) | 36,325 | 60,650 | 27,792 | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (116) | -37.297% | (185) | (415) | 137 | 163 |
| Depreciation & Amortisation | 234 | 54.967% | 151 | 201 | 291 | 1,272 |
| Directors' Emoluments | 755 | -34.689% | 1,156 | 260 | 156 | 99 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Qualified | -- | Qualified | Qualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -5.830 | 266.667% | -1.590 | 3.650 | 6.100 | 2.800 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.001 | -- | (0.005) | (0.010) | 0.019 | 0.000 |
| NBV per share ($) | 0.085 | -- | 0.143 | 0.156 | 0.119 | 0.057 |
| Remarks: | Real time quote last updated: 28/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 7,353,000 |
| %Change | 26.210% |
| EPS / (LPS) | RMB 0.007 |
| NBV Per Share (¥) | RMB 0.093 |